biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by frohlir944on Sep 07, 2017 10:50am

187 Views

Post# 26666136

proprietary xB3 BBB drug delivery tech

I love that we now have a marketing department and that we have our first Fantastic term "xB3" drug delivery tech

as quoted by the chair of our new scintific advisory board

"I am intrigued by the proprietary xB³BBB drug delivery technology that biOasis has developed"

Great things are starting to happen

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week